Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Organs-on-Chips Take Flight
Initiative to Use Technology Aboard International Space Station Set to Begin
For full access to this article login to GEN Select now.
Viral Clearance for Single Use and Steel
Don’t be satisfied with existing techniques for detecting and removing viral contaminants from recombinant bioproducts. Regulatory bodies aren’t.
- Viral clearance and quality control remain key challenges for biomanufacturers involved in both single-use and/or steel applications. New approaches and the latest thinking on ways to deal with viral clearance were topics of discussion at the recent Sartorius Stedim Biotech “European Upstream and Downstream Technology Forum,” which was held ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.